FILE PHOTO: Laura Ng, who has lupus and had to recently call at least five pharmacies before she could find a place to fill her hydroxychloroquine prescription, is photographed in Seattle, Washington, U.S. March 31, 2020. Ng said she is worried about the supply due to interest in the drug as a treatment for coronavirus disease (COVID-19). REUTERS/Lindsey Wasson
GENEVA (Reuters) – The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus sa